P Vernazza Selected Research

Darunavir (Prezista)

5/2011

Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Vernazza Research Topics

Disease

5	Infections 01/2015 - 08/2000
3	HIV Infections (HIV Infection) 09/2015 - 05/2011
3	Acquired Immunodeficiency Syndrome (AIDS) 08/2011 - 10/2004
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022
1	Hypertension (High Blood Pressure) 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Liver Diseases (Liver Disease) 09/2015
1	Obesity 09/2014
1	Disease Progression 08/2011
1	Latent Tuberculosis 05/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2010
1	Tuberculosis (Tuberculoses) 05/2010
1	Alcoholism (Alcohol Abuse) 01/2009
1	Liver Failure 01/2009
1	Chronic Hepatitis C 02/2005
1	Communicable Diseases (Infectious Diseases) 08/2000

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2022 - 08/2000
1	insulin receptor-related receptor (IRR)IBA 09/2015
1	Tenofovir (Viread)FDA Link 09/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	Darunavir (Prezista)FDA Link 05/2011
1	Interferon-gamma (Interferon, gamma)IBA 05/2010
1	Tuberculin (PPD)IBA 05/2010
1	EnzymesIBA 01/2009
1	Lamivudine (Epivir)FDA Link 01/2009
1	Opiate AlkaloidsIBA 02/2005
1	InterferonsIBA 02/2005
1	Ribavirin (Virazole)FDA LinkGeneric 02/2005

Therapy/Procedure

4	Therapeutics 01/2015 - 08/2001
2	Art Therapy 09/2014 - 01/2009
2	Highly Active Antiretroviral Therapy (HAART) 05/2011 - 10/2004